Advisors Capital Management LLC Buys 75,700 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• Advisors Capital Management increased its Healthpeak Properties holdings by 5%, buying 75,700 shares to own 1.58 million shares valued at approximately $33.7 million. Institutional investors collectively own 93.57% of the REIT.
• Healthpeak reported quarterly revenue of $771.6 million and adjusted earnings of $0.08 per share, exceeding analyst estimates, while revenue rose 11.1% year over year. The company issued fiscal 2026 EPS guidance of $1.73–$1.77.
• The company declared a monthly dividend of $0.1017 per share, representing an annualized yield of about 5.7%. Despite several analyst price-target increases, the stock has a consensus “Hold” rating and an average target price of $21.66.

Advisors Capital Management LLC raised its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 5.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,576,297 shares of the real estate investment trust's stock after purchasing an additional 75,700 shares during the quarter. Advisors Capital Management LLC owned 0.23% of Healthpeak Properties worth $33,733,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Integrated Wealth Concepts LLC grew its position in Healthpeak Properties by 7.3% during the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after buying an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust's stock worth $2,463,000 after buying an additional 63,930 shares in the last quarter. Woodline Partners LP lifted its stake in Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust's stock worth $1,195,000 after purchasing an additional 17,279 shares in the last quarter. Brown Advisory Inc. boosted its stake in Healthpeak Properties by 3.1% during the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust's stock valued at $819,000 after buying an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd purchased a new position in shares of Healthpeak Properties during the second quarter worth about $3,117,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Trading Up 2.3%

DOC opened at $21.24 on Friday. The stock has a 50-day moving average of $21.37 and a 200 day moving average of $19.00. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The firm has a market cap of $14.65 billion, a P/E ratio of 60.69, a P/E/G ratio of 3.20 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. During the same quarter in the previous year, the company posted $0.46 EPS. The company's revenue for the quarter was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.7%. Healthpeak Properties's payout ratio is currently 348.57%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on DOC. Barclays began coverage on Healthpeak Properties in a research note on Tuesday, July 7th. They issued an "equal weight" rating and a $23.00 target price for the company. JPMorgan Chase & Co. raised their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a "neutral" rating in a report on Wednesday, June 24th. Evercore lowered shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 price target for the company. in a research note on Monday, May 11th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Healthpeak Properties in a research report on Wednesday, August 5th. Finally, Mizuho upped their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research note on Monday, July 6th. Four research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company. According to MarketBeat, Healthpeak Properties currently has a consensus rating of "Hold" and an average target price of $21.66.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source